NPC
PFE icon

National Planning Corporation’s Pfizer PFE Stock Holding History

National Planning Corporation’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-108,119
Closed -$3.66M – 444
2017
Q3 		$3.66M Sell
108,119
-1,325
-1% -$42.6K 0.31% 68
2017
Q2 		$3.51M Buy
109,444
+13,395
+14% +$422K 0.27% 84
2017
Q1 		$3.13M Buy
96,049
+4,010
+4% +$126K 0.24% 91
2016
Q4 		$2.77M Buy
92,039
+1,681
+2% +$51.3K 0.22% 97
2016
Q3 		$2.6M Sell
90,358
-3,483
-4% -$116K 0.21% 105
2016
Q2 		$3.24M Buy
93,841
+4,193
+5% +$134K 0.25% 90
2016
Q1 		$2.86M Sell
89,648
-28,114
-24% -$803K 0.25% 87
2015
Q4 		$3.24M Buy
117,762
+34,286
+41% +$1.08M 0.27% 88
2015
Q3 		$2.7M Sell
83,476
-10,014
-11% -$321K 0.25% 84
2015
Q2 		$3.12M Sell
93,490
-901
-1% -$29.4K 0.28% 78
2015
Q1 		$3.06M Sell
94,391
-18,658
-17% -$593K 0.27% 82
2014
Q4 		$3.42M Sell
113,049
-5,176
-4% -$148K 0.24% 76
2014
Q3 		$3.28M Sell
118,225
-3,337
-3% -$93.7K 0.25% 76
2014
Q2 		$3.42M Buy
121,562
+16,025
+15% +$457K 0.27% 74
2014
Q1 		$3.23M Buy
105,537
+2,259
+2% +$67.4K 0.28% 70
2013
Q4 		$3M Buy
103,278
+7,277
+8% +$212K 0.27% 81
2013
Q3 		$2.63M Sell
96,001
-10,442
-10% -$284K 0.26% 84
2013
Q2 		$2.82M Buy
+106,443
New +$2.94M 0.35% 71

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

National Planning Corporation's PFE Position: Q4 2017 in Review

National Planning Corporation sold out of Pfizer (PFE) in Q4 2017, closing a stake of 108,119 shares — an estimated $3.66M sold.

National Planning Corporation first reported a position in PFE in Q2 2013 and held it in 18 quarters. The position peaked at $3.66M in Q3 2017. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • National Planning Corporation reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 108,119 Pfizer shares in Q4 2017, an estimated $3.66M.
  • National Planning Corporation first reported a position in Pfizer in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's Pfizer position peaked at $3.66M in Q3 2017.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.